A Future Focus for Parkinson’s Treatment
In a study published by the Journal of Biological Chemistry, scientists at UPenn School of Veterinary Medicine discovered that the enzyme cytochrome P450 2D6 (CYP2D6) plays a role in triggering Parkinson’s disease and represents a new focus for Parkinson’s treatment. Chemically induced Parkinson’s A few decades ago, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was found to induce the onset